Ultrarapid Influence of Buprenorphine on Major Depression in Opioid-Dependent Patients: A Double Blind, Randomized Clinical Trial

References

• Ahmadi J. (2016a). Fast treatment of methamphetamine related anxiety and depressive disorders: A novel approach. Journal of Addiction Medicine and Therapeutic Science, 1(2), 044–046, doi: 10.17352/2455-3484.000011
   Google Scholar
• Ahmadi J. (2016b). Instant detoxification of heroin with high dose of buprenorphine. Journal of Addiction & Prevention, 4(1), 3.
   Google Scholar
• Darke, S., Wodak, A., Hall, W., Heater, N., & Ward, J. (1992). Prevalence and predictors of psychopathology among opioid users. British Journal of Addiction, 87, 771–776.
   Google Scholar
• Dejong, C. A. J., Van Den Brink, W., Harteveld, F. M., & Van Der Wielen, E. G. M. (1993). Personality disorders in alcoholics and drug addicts. Comprehensive Psychiatry, 34, 87–94.
   Google Scholar
• Dorus, W., & Senay E. C. (1980). Depression, demographic dimensions, and drug abuse. American Journal of Psychiatry, 137, 699–704.
   Google Scholar
• Falcon, E., Maier, K., Robinson, S. A., Hill-Smith, T. E., & Lucki, I. (2015). Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice. Psychopharmacology, 232(5), 907–915.
   Google Scholar
• Fava, M., Memisoglu, A., Thase, M. E., Bodkin, A., Trivedi, M. H., Somer, M., … Ehrich, E. (2016). Opioid modulation with buprenorphine/samidorphan as adjunctive treatment for inadequate response to antidepressants: A randomized double-blind placebo-controlled trial. The American Journal of Psychiatry, 173(5), 499–508.
   Google Scholar
• Gerra, G., Leonardi, C., D'Amore, A., Strepparola, G., Fagetti, R., Assi, C., …Lucchini, A. (2006). Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30(2), 265–272.
   Google Scholar
• Gracer, R., The Buprenorphine Effect on Depression. (2007). The National Alliance of Advocates for Buprenorphine Treatment (NAABT) Feb. newsletter.
   Google Scholar
• Ipser, J. C., Terburg, D., Syal, S., Phillips, N., Solms, M., Panksepp, J., … van Honk, J. (2013). Reduced fear-recognition sensitivity following acute buprenorphine administration in healthy volunteers. Psychoneuroendocrinology, 38(1), 166–170.
   Google Scholar
• Karp, J. F., Butters, M. A., Begley, A., Miller, M. D., Lenze, E. J., Blumberger, D., … Reynolds, C. F. (2014). Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in mid-life and older adults. The Journal of Clinical Psychiatry, 75(8), e785–e793. doi:10.4088/JCP.13m08725
   Google Scholar
• Kosten, T. R., Rounsaville B. J., & Kleber, H. D. (1982). DSM-III personality disorders in opiate addicts. Comprehensive Psychiatry, 23, 572–581.
   Google Scholar
• Maremmani, A. G. I., Rovai, L., Pani, P. P., Pacini, M., Lamanna, F., Rugani, F., … Maremmani, I. (2011). Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?. Annals of General Psychiatry, 10(1), 1.
   Google Scholar
• Nace, E. P., Davis, C. W. & Gaspari, J. P. (1991). Axis II co-morbidity in substance abusers. American Journal of Psychiatry, 148, 118–120.
   Google Scholar
• Osório Fde, L., Sanches, R. F., Macedo, L. R., Santos, R. G., Maia-de-Oliveira, J. P., Wichert-Ana, L., … Hallak, J. E. (2015). Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A preliminary report. Revista Brasileira De Psiquiatria, 37(1), 13–20. doi:10.1590/1516-4446-2014-1496
   Google Scholar
• Rounsaville, B. J., Kosten, T., & Kleber, H. (1985). Success and failure at outpatient opioid detoxification. Evaluating the process of clonidine-and methadone-assisted withdrawal. Journal of Nervous and Mental Disease, 173, 103–110.
   Google Scholar
• Ross, H. E., Glaser, F. B., & Germanson, T. (1988). The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Archives of General Psychiatry, 45, 1023–1031.
   Google Scholar
• Rounsaville, B. J., Weissman, M. M., Kleber, H., & Wilber, C. (1982). Heterogeneity of psychiatric diagnosis in treated opiate addicts. Archives of General Psychiatry, 39, 161–166.
   Google Scholar
• Sadock, B. J., Sadock, V. A., & Ruiz, P. (2015). Substance use and addictive disorders. In: B. J. Sadock, V. A. Sadock, & P. Ruiz (Eds.), Kaplan & Sadock's synopsis of psychiatry (11th ed, pp. 616–93). Philadelphia: Lippincott Williams & Wilkins.
   Google Scholar
• Sanches, R. F., de Lima Osório, F., & Dos Santos Sanches, R. F. (2016). Antidepressant Effects of a Single Dose of Ayahuasca in Patients with Recurrent Depression: A SPECT Study. J Clin Psychopharmacol, 36(1), 77–81.
   Google Scholar
• Swift, W., Williams, G., Neill, O., & Grenyer, B. (1990). The prevalence of minor psychopathology in opioid users seeking treatment. British Journal of Addiction, 85, 629–634.
   Google Scholar
• Yovell, O., Bar, G., Mashiah, M., Baruch, Y., Briskman, I., Asherof, J., … Panksepp, J. (2016). Ultralow-dose buprenorphine as a time-limited treatment for severe suicidal ideation: A randomized controlled trial. The American Journal of Psychiatry, 173(5), 491–498.
   Google Scholar